ライフサイエンスコーパス: hospital-acquired infection

1 ry tract infections (caUTI), the most common hospital acquired infection.

2 ding causes of multiple antibiotic-resistant hospital-acquired infection.

3 e, and are now recognized as major agents of hospital-acquired infection.

4 ading causes of highly antibiotic-resistant, hospital-acquired infection.

5 Impaired neutrophil phagocytosis predicts hospital-acquired infection.

6 uals exposed to index case patients with non-hospital-acquired infection.

7 sistant Staphylococcus aureus as the primary hospital-acquired infection.

8 are vigorously focusing on reducing rates of hospital-acquired infection.

9 Clostridium difficile is a leading hospital-acquired infection.

10 teria that have emerged as leading causes of hospital-acquired infection.

11 ylococcus aureus is the most common cause of hospital-acquired infection.

12 ylococcus aureus is the most common cause of hospital-acquired infection.

13 ne of the most important causative agents of hospital acquired infections.

14 eat difficulties in the treatment of serious hospital-acquired infections.

15 in cost and patient morbidity attributed to hospital-acquired infections.

16 Enterococci are an important cause of hospital-acquired infections.

17 procedures place them at increased risk for hospital-acquired infections.

18 ngs that has recently emerged as a source of hospital-acquired infections.

19 s are a frequent source of life-threatening, hospital-acquired infections.

20 a bacterial pathogen of rising importance in hospital-acquired infections.

21 astrointestinal tract and a leading cause of hospital-acquired infections.

22 countermeasure to decrease the prevalence of hospital-acquired infections.

23 most common fungal pathogen responsible for hospital-acquired infections.

24 uman pathogen, is a frequent cause of severe hospital-acquired infections.

25 en Enterococcus faecalis, a leading cause of hospital-acquired infections.

26 ff, shorter hospital stays, and avoidance of hospital-acquired infections.

27 hey are causative agents of life-threatening hospital-acquired infections.

28 tinal domination by bacteria associated with hospital-acquired infections.

29 aeruginosa has emerged as a major source of hospital-acquired infections.

30 ium Pseudomonas aeruginosa frequently causes hospital-acquired infections.

31 creased compliance with practices to prevent hospital-acquired infections.

32 ic-resistant enterococci are major causes of hospital-acquired infections.

33 ents may be a vector for the transmission of hospital-acquired infections.

34 ical for optimal treatment and prevention of hospital-acquired infections.

35 ential element of public health planning for hospital-acquired infections.

36 otential reservoirs for either community- or hospital-acquired infections.

37 individuals with community-acquired (CA) and hospital-acquired infections.

38 us epidermidis, are the predominant cause of hospital-acquired infections.

39 odel to quantify key elements in nosocomial (hospital-acquired) infections.

40 It is a major cause of hospital-acquired infection; a large number of those exp

41 ary tract infection (CAUTI) is the commonest hospital-acquired infection, accounting for over 100,000

42 increased for most pathogens associated with hospital-acquired infections among ICU patients, and rat

43 nnii is a significant cause of opportunistic hospital acquired infection and has been identified as a

44 ) represents the second most common cause of hospital-acquired infection and the most common type of

45 responsible for manifold problems, including hospital-acquired infections and biofouling, but they ca

46 one of the most common etiological agents in hospital-acquired infections and food-borne illness.

47 eruginosa have become a concerning threat in hospital-acquired infections and for cystic fibrosis pat

48 ces as well as increased patient exposure to hospital-acquired infections and functional decline.

49 Enterococci are major contributors of hospital-acquired infections and have emerged as importa

50 trating their potential as a tool to control hospital-acquired infections and help direct surveillanc

51 gen, causes acute pneumonia in patients with hospital-acquired infections and is commonly associated

52 Pseudomonas aeruginosa is a leading cause of hospital-acquired infections and is resistant to many an

53 Increasing antibiotic resistant hospital-acquired infections and limited new antibiotic

54 or obese was associated with higher risk of hospital-acquired infections and lower likelihood of hos

55 etiology of infection and for community- and hospital-acquired infections and occurred despite a lowe

56 ng for age, history of pneumonia, history of hospital-acquired infection, and history of sepsis.

57 , age, sex, comorbidities, community- versus hospital-acquired infection, and organism type.

58 nts with sepsis at admission who developed a hospital-acquired infection, and those who received a lo

59 Pseudomonas aeruginosa is a major agent of hospital-acquired infections, and a pathogen of immunoco

60 Hospital-acquired infections are an increasingly serious

61 es from patients with confirmed or suspected hospital-acquired infections, as well as isolates obtain

62 valuated the performance of a new NGS assay (Hospital Acquired Infection BioDetection System; Pathoge

63 main one of the few valid treatments against hospital-acquired infections by Gram-negative bacteria.

64 Hospital-acquired infections caused by antibiotic-resist

65 study was performed to assess the impact of hospital-acquired infections caused by MDROs on morbidit

66 enomic sequence in the two of the cases with hospital-acquired infection, consistent with the concern

67 ,122 of 45,209 (43%) deaths in patients with hospital-acquired infection due to MDR bacteria in Thail

68 Hospital-acquired infection due to meticillin-resistant

69 Enterococcus faecalis, a leading cause of hospital-acquired infections, exhibits intrinsic resista

70 of two most common pathogens responsible for hospital acquired infections: gram-positive Staphylococc

71 The performance of the hospital-acquired infection (HAI) BioDetection System fo

72 Little is known regarding the impact of hospital-acquired infection (HAI) in acute pancreatitis

73 Postoperative hospital-acquired infections (HAIs) may result from disr

74 smission of VRE and aid in the prevention of hospital-acquired infections (HAIs).

75 Mortality was increased in hospital-acquired infection (hospital, 17/36 [47%]; comm

76 ting resistance in community-acquired versus hospital-acquired infections, implementation of standard

77 decreasing the rates of intensive care unit hospital-acquired infections in the past decade.

78 ne of the most common bacterial pathogens in hospital-acquired infections in the United States.

79 difficile is currently the leading cause of hospital-acquired infections in the United States.

80 Approximately 60% of hospital-acquired infections included bacteria frequentl

81 forts to prevent complications stemming from hospital-acquired infection is commendable, these effort

82 easing frequency of antibiotic resistance in hospital-acquired infections is a major public health co

83 f) is one of the most common and most severe hospital-acquired infections; its consequences range fro

84 ody mass index z score, to 60-day mortality, hospital-acquired infections, length of hospital stay, a

85 Bacteria that cause most of the hospital-acquired infections make use of class C beta-la

86 ltiplex detection of sequences relating to a hospital-acquired infection, namely, methicillin-resista

87 ceived susceptibility and severity towards a hospital-acquired infection or a misidentification error

88 th sepsis at admission and did not develop a hospital-acquired infection or those who presented witho

89 linical isolates obtained from patients with hospital-acquired infections or with cystic fibrosis.

90 Hospital-acquired infection rates were not different bet

91 s morbidity (hospital-acquired and resistant hospital-acquired infection rates) on the non-ICU wards

92 Of all CDI, hospital-acquired infection remains more common.

93 However, OmpA clinical implication in hospital-acquired infections remains unknown.

94 gn of novel therapeutics that combat severe, hospital-acquired infections resistant to the establishe

95 um difficile infection (CDI) is an important hospital-acquired infection resulting from the germinati

96 n their index admission who also developed a hospital-acquired infection ("second hit") were nearly t

97 Rates of hospital-acquired infections, specifically methicillin-r

98 Enterococci commonly cause hospital-acquired infections, such as infective endocard

99 ial control measures are typically faster in hospital-acquired infections than in community-acquired

100 hylococcus aureus (MRSA) is a major cause of hospital-acquired infections that are becoming increasin

101 However, as shown in the recent reduction in hospital acquired infections, the number of deaths could

102 year about 400,000 patients die from sepsis, hospital acquired infections, venous thromboembolism, an

103 The absolute risk reduction for acquiring a hospital-acquired infection was 9.0% (95% CI, 1.5-16.4%;

104 ter versus chlorhexidine, counts of incident hospital-acquired infections were 14 versus 7 for cathet

105 The odds of hospital-acquired infections were higher in underweight

106 Hospital-acquired infections were reduced by 50%.

107 Of these patients, 407 hospital-acquired infections were treated during the non

108 species are responsible for the majority of hospital-acquired infections, which are often complicate

109 ere common among human carriage isolates and hospital-acquired infections, which generally lacked the

110 Recently, an increased incidence of hospital-acquired infections with severe outcomes has be

111 ance quality-improvement efforts to minimize hospital-acquired infections with VRE.

112 ommon cause of severe community-acquired and hospital-acquired infection worldwide.

113 ract infections (CaUTIs) are the most common hospital-acquired infections worldwide and are frequentl

114 inetobacter baumannii is a frequent cause of hospital-acquired infections worldwide and is a challeng

115 cus aureus is the leading cause of wound and hospital-acquired infections worldwide.